Oral administration of curcumin (curcuma Longa) can attenuate the neutrophil inflammatory response in zymosan-induced arthritis in rats

PURPOSE: To evaluate the effect of curcumin in the acute phase of zymosan-induced arthritis.METHODS: Twenty-eight male rats were subjected to intra-articular infiltration of zymosan of both knees and, in four the infiltration was made with saline. The animals were divided into five groups second received every six hours by gavage: corn oil by (positive and negative control); curcumin (100 mg/kg); prednisone 1 mg/kg/day; prednisone 8 mg/kg. All animals were sacrificed after six, 12, 24 and 48 hours of the infiltration. The knees were removed for evaluation of neutrophil infiltration. The number of neutrophils was counted by computer-assisted analysis of the images. The neutrophil infiltrate was stratified into four grades: 0 = normal; + = mild; ++/+++ = moderate; > ++++ = severe. The results were compared using the Mann-Whitney test and the variance by Kruskal-Wallis test adopting a significance level of 5% (p<0.05).RESULTS: Curcumin reduces inflammatory activity in the first six hours after zymosan-induced arthritis when compared to saline (p<0.01). This was also observed in animals subjected to administration of prednisone (1 mg/kg) and those treated with prednisone (8 mg/kg). Curcumin was more effective than lower doses of prednisone in the first six hours after induction of the arthritis. After 12, 24 and 48 hours, curcumin does not have the same anti-inflammatory effects when compared to prednisone. After 48 hours, prednisone is more effective than curcumin in reducing the inflammatory infiltrate regardless of the dose of prednisone used.CONCLUSION: Oral administration of curcumin reduces inflammation in the first six hours after experimentally zymosan-induced arthritis.To evaluate the effect of curcumin in the acute phase of zymosan-induced arthritis.METHODS: Twenty-eight male rats were subjected to intra-articular infiltration of zymosan of both knees and, in four the infiltration was made with saline. The animals were2911727734sem informaçãosem informaçãoLawrence, R.C., Felson, D.T., Helmick, C.G., Arnold, L.M., Choi, H., Deyo, R.A., Gabriel, S., Wolfe, F., National Arthritis Data Workgroup. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II (2008) Arthritis Rheum, 58 (1), pp. 26-35. , JanMahajan, A., Verma, S., Tandon, V., Osteoarthritis (2005) J Ass Physicians India, 53, pp. 634-641. , Jul, PMID: 16190135Arden, N., Nevitt, M.C., Osteoarthritis: Epidemiology (2006) Best Pract Res Clin Rheumatol, 20 (1), pp. 3-25. , Feb, PMID:16483904Dibonaventura, M., Gupta, S., McDonald, M., Sadosky, A., Evaluating the health and economic impact of osteoarthritis pain in the workforce: results from the National Health and Wellness Survey (2011) BMC Musculoskelet Disord, 12, p. 83. , Apr 28Rocha, F.A., Andrade, L.E., Jancar, S., Immune complex induced arthritis in rats: Role of lipid mediators on cell infiltration (1996) Med Inflam, 5 (2), pp. 104-109. , PMID: 18475706Henrotin, Y.E., Bruckner, P., Pujol, J.P., The role of reactive oxygen species in homeostasis and degradation of cartilage (2003) Osteoarthritis Cartilage, 11 (10), pp. 747-755. , Oct, PMID:13129694Fermor, B., Christensen, S.E., Youn, I., Cernanec, J.M., Davies, C.M., Weinberg, J.B., Oxygen, nitric oxide and articular cartilage (2007) Eur Cell Mater., 13, pp. 56-65. , Apr 11, discussion 65, PMID: 17427142Jurenka, J.S., Anti-inflammatory properties of curcumin, a major constituent of Curcuma longa: A review of pre-clinical and clinical research (2009) Altern Med Rev, 14 (2), pp. 141-153. , Jun, PMID:19594223Chopra, A., Lavin, P., Patwardhan, B., Chitre, D., A 32-week randomized, placebo-controlled clinical evaluation of RA-11, an Ayurvedic drug, on osteoarthritis of the knees (2004) Clin Rheumatol, 10 (5), pp. 236-245. , Oct, PMID: 17043520Park, C., Moon, D.O., Choi, I.W., Choi, B.T., Nam, T.J., Rhu, C.H., Kwon, T.K., Choi, Y.H., Curcumin induces apoptosis and inhibits prostaglandin E(2) production in synovial fibroblasts of patients with rheumatoid arthritis (2007) Int J Mol Med, 20 (3), pp. 365-372. , Sep, PMID: 17671742Funk, J.L., Oyarzo, J.N., Frye, J.B., Chen, G., Lantz, R.C., Jolad, S.D., Sólyom, A.M., Timmermann, B.N., Turmeric extracts containing curcuminoids prevent experimental rheumatoid arthritis (2006) J Nat Prod, 69 (3), pp. 351-355. , Mar, PMID: 16562833Chaves, H.V., Ribeiro R De, A., De Souza, A.M., Rodrigues E Silva, A.A., Gomes, A.S., Vale, M.L., Bezerra, M.M., Brito, G.A., Experimental model of zymosan-induced arthritis in the rat temporomandibular joint: Role of nitric oxide and neutrophils (2011) J Biomed Biotechnol, 2011, p. 707985Keystone, E.C., Schorlemmer, H.U., Pope, C., Allison, A.C., Zymosan-induced arthritis: A model of chronic proliferative arthritis following activation of the alternative pathway of complement (1977) Arthritis Rheum, 20 (7), pp. 1397-1401. , Sep-Oct, PMID: 911357Gegout, P., Gillet, P., Terlain, B., Netter, P., Zymosan induced arthritis in rats II. Effects of antiinflammatory drugs (1995) Life Sci, 56 (20), pp. PL389-PL394. , PMID: 7723595Berner, J., Gabay, C., Best practice use of corticosteroids in rheumatoid arthritis (2014) Rev Med Suisse, 10 (421), pp. 603-608. , Mar 12, PMID: 24701713Narendhirakannan, R.T., Limmy, T.P., Anti-inflammatory and anti-oxidant properties of Sida rhombifolia stems and roots in adjuvant induced arthritic rats (2012) Immunopharmacol Immunotoxicol, 34 (2), pp. 326-336. , AprAggarwal, B.B., Sundaram, C., Malani, N., Ichikaw, H., Curcumin: The Indian solid gold (2007) Adv Exp Med Biol, 595, pp. 1-75. , PMID: 17569205Anand, P., Kunnumakkara, A.B., Newman, R.A., Aggarwal, B.B., Bioavailability of curcumin: Problems and promises (2007) Mol Pharm, 4 (6), pp. 807-818. , Nov-Dec, PMID: 17999464Taty Anna, K., Elvy Suhana, M.R., Faizah, O., Hamzaini, A.H., Anti-inflammatory effect of Curcuma longa (turmeric) on collagen-induced arthritis: An anatomico-radiological study (2011) Clin Ter, 162 (3), pp. 201-207. , PMID: 21717043Shishodia, S., Sethi, G., Aggarwal, B.B., Curcumin: Getting back to the roots (2005) Ann N Y Acad Sci, 1056, pp. 206-217. , Nov, PMID: 16387689Samuhasaneeto, S., Thong-Ngam, D., Kulaputana, O., Suyasunanont, D., Klaikeaw, N., Curcumin decreased oxidative stress, inhibited NF- kappaB activation, and improved liver pathology in ethanol-induced liver injury in rats (2009) J Biomed Biotechnol, 2009, p. 981963Ramadan, G., Al-Kahtani, M.A., El-Sayed, W.M., Anti-inflammatory and anti-oxidant properties of Curcuma longa (turmeric) versus Zingiber officinale (ginger) rhizomes in rat adjuvant-induced arthritis (2011) Inflammation, 34 (4), pp. 291-301. , AugPark, C., Moon, D.O., Choi, I.W., Choi, B.T., Nam, T.J., Rhu, C.H., Kwon, T.K., Choi, Y.H., Curcumin induces apoptosis and inhibits prostaglandin E(2) production in synovial fibroblasts of patients with rheumatoid arthritis (2007) Int J Mol Med, 20 (3), pp. 365-372. , Sep, PMID: 17671742Mun, S.H., Kim, H.S., Kim, J.W., Ko, N.Y., Kim, D.O.K., Lee, B.Y., Kim, B., Choi, W.S., Oral administration of curcumin suppresses production of matrix metalloproteinase (MMP)-1 and MMP-3 to ameliorate collagen- induced arthritis: Inhibition of the PKCdelta/JNK/c-Jun pathway (2009) J Pharmacol Sci, 111 (1), pp. 13-21. , Sep, PMID: 19763044Moon, D.O., Kim, M.O., Choi, Y.H., Park, Y.M., Kim, G.Y., Curcumin attenuates inflammatory response in IL-1beta-induced human synovial fibroblasts and collagen-induced arthritis in mouse model (2010) Int Immunopharmacol, 10 (5), pp. 605-610. , MayLantz, R.C., Chen, G.J., Solyom, A.M., Jolad, S.D., Timmermann, B.N., The effect of turmeric extracts on inflammatory mediator production (2005) Phytomedicine, 12 (6-7), pp. 445-452. , Jun, PMID: 16008121Srimal, R.C., Dhawan, B.N., Pharmacology of diferuloyl methane (curcumin), a non-steroidal antiinflammatory agent (1973) J Pharm Pharmacol, 25 (6), pp. 447-452. , Jun, PMID: 4146582Baker, C.L., Jr., Ferguson CM. Future treatment of osteoarthritis (2005) Orthopedics, 28 (2), pp. s227-s234. , Feb, PMID: 15747611Banerjee, M., Tripathi, L.M., Srivastava, V.M., Puri, A., Shukla, R., Modulation of inflammatory mediators by ibuprofen and curcumin treatment during chronic inflammation in rat (2003) Immunopharmacol Immunotoxicol, 25 (2), pp. 213-224. , May, PMID: 12784914Banji, D., Pinnapureddy, J., Banji, O.J., Saidulu, A., Hayath, M.S., Synergistic activity of curcumin with methotrexate in ameliorating Freund’s Complete Adjuvant induced arthritis with reduced hepatotoxicity in experimental animals (2011) Eur J Pharmacol, 668 (1-2), pp. 293-298. , Oct 1Funk, J.L., Frye, J.B., Oyarzo, J.N., Kuscuoglu, N., Wilson, J., McCaffrey, G., Stafford, G., Timmermann, B.N., Efficacy and mechanism of action of turmeric supplements in the treatment of experimental arthritis (2006) Arthritis Rheum, 54 (11), pp. 3452-3464. , Nov, PMID: 17075840Jancinová, V., Perecko, T., Nosál, R., Kostálová, D., Bauerová, K., Drábiková, K., Decreased activity of neutrophils in the presence of diferuloylmethane (curcumin) involves protein kinase C inhibition (2009) Eur J Pharmacol, 612 (1-3), pp. 161-166. , Jun 10Joe, B., Rao, U.J., Lokesh, B.R., Presence of an acidic glycoprotein in the serum of arthritic rats: Modulation by capsaicin and curcumin (1997) Mol Cell Biochem, 169 (1-2), pp. 125-134. , Apr, PMID: 908963

Phase transitions for the Lifshitz black holes

We study possibility of phase transitions between Lifshitz black holes and other configurations by using free energies explicitly. A phase transition between Lifshitz soliton and Lifshitz black hole might not occur in three dimensions. We find that a phase transition between Lifshitz and BTZ black holes unlikely occurs because they have different asymptotes. Similarly, we point out that any phase transition between Lifshitz and black branes unlikely occurs in four dimensions since they have different asymptotes. This is consistent with a necessary condition for taking a phase transition in the gravitational system, which requires the same asymptote.Comment: 19 pages, 7 figures, a revised version to appear in EPJ

Oxidative Stress And Changes In The Content And Pattern Of Tissue Expression Of β-catenin Protein In Diversion Colitis

Objective: The aim of this study is to verify if oxidative stress is related to changes in content and pattern of β-catenin protein expression in an experimental model of diversion colitis. Methods: Sixty Wistar rats were submitted to intestinal bypass. The animals were divided into three groups according to the sacrifice to take place in six, 12 and 18 weeks. For each group, five animals only underwent laparotomy (control). The presence of colitis was diagnosed by histological study, and its severity, by inflammation grading scale. Cellular oxidative stress was measured by comet assay. Tissue expression of β-catenin protein was analyzed by the immunohistochemistry and quantification of its tissue content by computerized morphometry. Statistical analysis was performed with the Student's t-test, median, Mann-Whitney, ANOVA and Kruskal-Wallis, adopting a significance level of 5% (p <0.05). Results: Colon segments without fecal stream developed colitis, which worsened with time of exclusion. Segments without fecal stream suffer higher levels of oxidative stress when compared to those with stream, and it worsens with time of exclusion. The levels of cellular oxidative stress are directly related to the degree of inflammation. The total content of β-catenin in segments without fecal stream reduces after six weeks, and does not vary thereafter. The content of β-catenin in the apical portion of the colon crypts decreases with time, whereas in the basal region, it increases. The total content of β-catenin is inversely related to the degree of inflammation and levels of tissue oxidative stress levels. Conclusion: There are changes in tissue content of E-cadherin and increased expression of β-catenin in proliferative regions of colonic crypts, related with oxidative tissue stress.324343358Pravda, J., Radical induction theory of ulcerative colitis (2005) World J Gastroenterol, 11 (16), pp. 2371-2384Gaudier, E., Hoebler, C., Physiological role of mucins in the colonic barrier integrity (2006) Gastroenterol Clin Biol, 30 (8-9), pp. 965-974Laukoetter, M.G., Nava, P., Nusrat, A., Role of the intestinal barrier in inflammatory bowel disease (2008) World J Gastroenterol, 14 (3), pp. 401-407Berkes, J., Viswananthan, V.K., Savkovic, S.D., Hecht, G., Intestinal epithelial responses to enteric pathogens: Effects on the tight junction barrier, iron transport, and inflammation (2003) Gut, 52 (3), pp. 439-451Clayburgh, D.R., Shen, L., Turner, J.R., A porous defense: The leaky epithelial barrier in intestinal disease (2004) Lab Invest, 84 (3), pp. 282-291Usami, Y., Chiba, H., Nakayama, F., Ueda, J., Matsuda, Y., Sawada, N., Reduced expression of claudin-7 correlates with invasion and metastasis in squamous cell carcinoma of the esophagus (2006) Hum Pathol, 37 (5), pp. 569-577Gumbiner, B., Stevenson, B., Grimaldi, A., The role of the cell adhesion molecule uvomorulin in the formation and maintenance of the epithelial junctional complex (1988) J Cell Biol, 107 (4), pp. 1575-1587Gumbiner, B.M., McCrea, P.D., Catenins as mediators of the cytoplasmic functions of cadherins (1993) J Cell Sci Suppl, 17, pp. 155-158Yeager, M., Unger, V.M., Falk, M.M., Synthesis, assembly and structure of gap junction intercellular channels (1998) Curr Opin Struct Biol, 8 (6), pp. 810-811Hynes, R.O., Zhao, Q., The evolution of cell adhesion (2000) J Cell Biol, 150 (2), pp. F89-F96Kypta, R., Bernfield, M., Burridge, K., Geiger, B., Goodenough, D., Humphries, M., Hynes, R., Yurchenco, P., Junções celulares, adesão celular e matriz extracelular (2006) Biologia Molecular Da Célula, pp. 1065-1125. , In: Alberts B, Johnson A, Lewis J, Raff M, Roberts K, Walter P. (eds.), Porto Alegre: ARTMEDDemetter, P., de Vos, M., van Damme, N., Baeten, D., Elewaut, D., Vermeulen, S., Focal up-regulation of E-cadherin catenin complex in inflamed bowel mucosa but reduced expression in ulcer-associated cell lineage (2000) Am J Clin Pathol, 114 (3), pp. 364-370Aust, D.E., Terdiman, J.P., Willenbucher, R.F., Chew, K., Ferrell, L., Florendo, C., Altered distribution of β-catenin, and its binding proteins E-cadherin and APC, in ulcerative colitisrelated colorectal cancers (2001) Mod Pathol, 14 (1), pp. 29-39Kucharzik, T., Walsh, S.V., Chen, J., Parkos, C.A., Nusrat, A., Neutrophil transmigration in inflammatory bowel disease is associated with differential expression of epithelial intercellular junction proteins (2001) Am J Pathol, 159 (6), pp. 2001-2009Laukoetter, M.G., Nava, P., Nusrat, A., Role of the intestinal barrier in inflammatory bowel disease (2008) World J Gastroenterol, 14 (3), pp. 401-407Gassler, N., Rohr, C., Schneider, A., Kartenbeck, J., Bach, A., Obermüller, N., Inflammatory bowel disease is associated with changes of enterocytic junctions (2001) Am J Physiol Gastrointest Liver Physiol, 281 (1), pp. G216-G228Ozawa, M., Ringwald, M., Kemler, R., Uvomorulin-catenin complex formation is regulated by a specific domain in the cytoplasmic region of the cell adhesion molecule (1990) Proc Natl Acad Sci USA, 87 (11), pp. 4246-4250Schmitz, H., Barmeyer, C., Fromm, M., Runkel, N., Foss, H.D., Bentzel, C.J., Altered tight junction structure contributes to the impaired epithelial barrier function in ulcerative colitis (1999) Gastroenterology, 116 (2), pp. 301-309Takahashi, M., Fukuda, K., Sugimura, T., Wakabayashi, K., Beta-catenin is frequently mutated and demonstrates altered cellular localization in azoxymethane-induced rat colon tumors (1998) Cancer Res, 58 (1), pp. 42-46Parrish, A.R., Catania, J.M., Orozco, J., Gandolfi, A.J., Chemically induced oxidative stress disrupts the E-cadherin/catenin cell adhesion complex (1999) Toxicol Sci, 51 (1), pp. 80-86Meyer, T.N., Schwesinger, C., Ye, J., Denker, B.M., Nigam, S.K., Reassembly of the tight junction after oxidative stress depends on tyrosine kinase activity (2001) J Biol Chem, 276 (25), pp. 22048-22055Dorudi, S., Sheffield, J.P., Poulsom, R., Northover, J.M., Hart, I.R., E-cadherin expression in colorectal cancer. An immunocytochemical and in situ hybridization study (1998) Am J Pathol, 142 (4), pp. 981-986Chen, J., Huang, X.F., The signal pathways in azoxymethane induced colon cancer and preventive implications (2009) Cancer Biol Ther, 8 (14), pp. 1313-1317Jankowski, J.A., Bedford, F.K., Boulton, R.A., Cruickshank, N., Hall, C., Elder, J., Alterations in classical cadherins associated with progression in ulcerative and Crohn's colitis (1998) Lab Invest, 78 (9), pp. 1155-1167Hermiston, M.L., Gordon, J.I., Inflammatory bowel disease and adenomas in mice expressing a dominant negative N-cadherin (1995) Science, 270 (5239), pp. 1203-1207Karayiannakis, A.J., Syrigos, K.N., Efstathiou, J., Valizadeh, A., Noda, M., Playford, R.J., Expression of catenins and E-cadherin during epithelial restitution in inflammatory bowel disease (1998) J Pathol, 185 (4), pp. 413-418Nollet, F., Berx, G., van Roy, F., The role of the E-cadherin/ catenin adhesion complex in the development and progression of cancer (1999) Mol Cell Biol Res Commun, 2 (2), pp. 77-85Sheehan, J.F., Brynjolfsson, G., Ulcerative colitis following hydrogen peroxide enema: Case report and experimental production with transient emphysema of colonic wall and gas embolism (1960) Lab Invest, 9, pp. 150-168Marques, L.H.S., Silva, C.M.G., Lameiro, T.M.M., Almeida, M.G., Cunha, F.L., Pereira, J.A., Avaliação dos níveis de peroxidação lipídica em células da mucosa cólica após aplicação de enemas com peróxido de hidrogênio: Estudo experimental em ratos (2010) Rev Bras Colo-proctol, 30 (3), pp. 272-280Martinez, C.A., Ribeiro, M.L., Gambero, A., Miranda, D.D., Pereira, J.A., Nadal, S.R., The importance of oxygen free radicals in the etiopathogenesis of diversion colitis in rats (2010) Acta Cir Bras, 25 (5), pp. 387-395Longatti, T.S., Acedo, S.C., de Oliveira, C.C., Miranda, D.D., Priolli, D.G., Ribeiro, M.L., Inflammatory alterations in excluded colon in rats: A comparison with chemically induced colitis (2010) Scand J Gastroenterol, 45 (3), pp. 315-324Damiani, C.R., Benetton, C.A., Stoffel, C., Bardini, K.C., Cardoso, V.H., Di Giunta, G., Oxidative stress and metabolism in animal model of colitis induced by dextran sulfate sodium (2007) J Gastroenterol Hepatol, 22 (11), pp. 1846-1851Liu, Q., Shimoyama, T., Suzuki, K., Umeda, T., Nakaji, S., Sugawara, K., Effect of sodium butyrate on reactive oxygen species generation by human neutrophils (2001) Scand J Gastroenterol, 36 (7), pp. 744-750Glotzer, D.J., Glick, M.E., Goldman, H., Proctitis and colitis following diversion of the fecal stream (1981) Gastroenterology, 80 (3), pp. 438-441Agarwal, V.P., Schimmel, E.M., Diversion colitis: A nutritional deficiency syndrome? (1989) Nutr Rev, 47 (9), pp. 257-261Butzner, J.D., Parmar, R., Bell, C.J., Dalal, V., Butyrate enema therapy stimulates mucosal repair in experimental colitis in the rat (1996) Gut, 38 (4), pp. 568-573Nonose, R., Spadari, A.P., Priolli, D.G., Máximo, F.R., Pereira, J.A., Martinez, C.A., Tissue quantification of neutral and acid mucins in the mucosa of the colon with and without fecal stream in rats (2009) Acta Cir Bras, 24 (4), pp. 267-275Martinez, C.A., Nonose, R., Spadari, A.P., Máximo, F.R., Priolli, D.G., Pereira, J.A., Quantification by computerized morphometry of tissue levels of sulfomucins and sialomucins in diversion colitis in rats (2010) Acta Cir Bras, 25 (3), pp. 231-240Sousa, M.V., Priolli, D.G., Portes, A.V., Cardinalli, I.A., Pereira, J.A., Martinez, C.A., Evaluation by computerized morphometry of histopathological alterations of the colon wall in segments with and without intestinal transit in rats (2008) Acta Cir Bras, 23 (5), pp. 417-424Caltabiano, C., Máximo, F.R., Spadari, A.P., Miranda, D.D.C., Serra, M.M., Ribeiro, M.L., 5-aminosalicylic (5-ASA) can reduce the levels of oxidative DNA damage in cells of colonic mucosa with and without fecal stream (2011) Dig Dis Sci, 56 (4), pp. 1037-1046Gupta, R.B., Harpaz, N., Itzkowitz, S., Hossain, S., Matula, S., Kornbluth, A., Histologic inflammation is a risk factor for progression to colorectal neoplasia in ulcerative colitis: A cohort study (2007) Gastroenterology, 133 (4), pp. 1099-1105Ribeiro, M.L., Priolli, D.G., Miranda, D.D., Arçari, D.P., Pedrazzoli Jr., J., Martinez, C.A., Analysis of oxidative DNA damage in patients with colorectal cancer (2008) Clin Colorectal Cancer, 7 (4), pp. 267-272Lodish, H., Berk, A., Zipursky, S.L., Matsudaira, P., Baltimore, D., Darnell, J., A integração das células nos tecidos (2004) Biologia Celular E Molecular, pp. 968-1002. , In: Lodish H, Berk A, Zipursky SL, Matsudaira P, Baltimore D, Darnell J. (eds.), Rio de Janeiro: RevinterDuband, J.L., Thiery, J.P., Spatio-temporal distribution of the adherens junction-associated molecules vinculin and talin in early avian embryo (1990) Cell Differ Dev, 30 (1), pp. 55-76Rao, R.K., Basuroy, S., Rao, V.U., Karnaky, K.J., Gupta, A., Tyrosine phosphorylation and dissociation of occludin-ZO-1 and E-cadherin-b-catenin complexes from the cytoskeleton by oxidative stress (2002) Biochem J, 368 (PART. 2), pp. 471-481Schmehl, K., Florian, S., Jacobasch, G., Salomon, A., Körber, J., Deficiency of epithelial basement membrane laminin in ulcerative colitis affected human colonic mucosa (2000) Int J Colorectal Dis, 15 (1), pp. 39-48Cooper, H.S., Murthy, S., Kido, K., Yoshitake, H., Flanigan, A., Dysplasia and cancer in the dextran sulfate sodium mouse colitis model. Relevance to colitis-associated neoplasia in the human: A study of histopathology, B-catenin and p53 expression and the role of inflammation (2000) Carcinogenesis, 21 (4), pp. 757-768Fodde, R., Tomlinson, I., Nuclear beta-catenin expression and Wnt signalling: In defence of the dogma (2010) J Pathol, 221 (3), pp. 239-241Baskol, M., Baskol, G., Koçer, D., Ozbakir, O., Yucesoy, M., Advanced oxidation protein products: A novel marker of oxidative stress in ulcerative colitis (2008) J Clin Gastroenterol, 42 (6), pp. 687-691Glei, M., Hovhannisyan, G., Pool-Zobel, B.L., Use of Comet-fish in the study of DNA damage and repair: Review (2009) Mutat Res, 681 (1), pp. 33-4

Magnetism in Dense Quark Matter

We review the mechanisms via which an external magnetic field can affect the ground state of cold and dense quark matter. In the absence of a magnetic field, at asymptotically high densities, cold quark matter is in the Color-Flavor-Locked (CFL) phase of color superconductivity characterized by three scales: the superconducting gap, the gluon Meissner mass, and the baryonic chemical potential. When an applied magnetic field becomes comparable with each of these scales, new phases and/or condensates may emerge. They include the magnetic CFL (MCFL) phase that becomes relevant for fields of the order of the gap scale; the paramagnetic CFL, important when the field is of the order of the Meissner mass, and a spin-one condensate associated to the magnetic moment of the Cooper pairs, significant at fields of the order of the chemical potential. We discuss the equation of state (EoS) of MCFL matter for a large range of field values and consider possible applications of the magnetic effects on dense quark matter to the astrophysics of compact stars.Comment: To appear in Lect. Notes Phys. "Strongly interacting matter in magnetic fields" (Springer), edited by D. Kharzeev, K. Landsteiner, A. Schmitt, H.-U. Ye

Effect of Lanadelumab Compared with Placebo on Prevention of Hereditary Angioedema Attacks : a Randomized Clinical Trial

Importance: Current treatments for long-term prophylaxis in hereditary angioedema have limitations. Objective: To assess the efficacy of lanadelumab, a fully human monoclonal antibody that selectively inhibits active plasma kallikrein, in preventing hereditary angioedema attacks. Design, Setting, and Participants: Phase 3, randomized, double-blind, parallel-group, placebo-controlled trial conducted at 41 sites in Canada, Europe, Jordan, and the United States. Patients were randomized between March 3, 2016, and September 9, 2016; last day of follow-up was April 13, 2017. Randomization was 2:1 lanadelumab to placebo; patients assigned to lanadelumab were further randomized 1:1:1 to 1 of the 3 dose regimens. Patients 12 years or older with hereditary angioedema type I or II underwent a 4-week run-in period and those with 1 or more hereditary angioedema attacks during run-in were randomized. Interventions: Twenty-six-week treatment with subcutaneous lanadelumab 150 mg every 4 weeks (n = 28), 300 mg every 4 weeks (n = 29), 300 mg every 2 weeks (n = 27), or placebo (n = 41). All patients received injections every 2 weeks, with those in the every-4-week group receiving placebo in between active treatments. Main Outcome and Measures: Primary efficacy end point was the number of investigator-confirmed attacks of hereditary angioedema over the treatment period. Results: Among 125 patients randomized (mean age, 40.7 years [SD, 14.7 years]; 88 females [70.4%]; 113 white [90.4%]), 113 (90.4%) completed the study. During the run-in period, the mean number of hereditary angioedema attacks per month in the placebo group was 4.0; for the lanadelumab groups, 3.2 for the every-4-week 150-mg group; 3.7 for the every-4-week 300-mg group; and 3.5 for the every-2-week 300-mg group. During the treatment period, the mean number of attacks per month for the placebo group was 1.97; for the lanadelumab groups, 0.48 for the every-4-week 150-mg group; 0.53 for the every-4-week 300-mg group; and 0.26 for the every-2-week 300-mg group. Compared with placebo, the mean differences in the attack rate per month were -1.49 (95% CI, -1.90 to -1.08; P &lt;.001); -1.44 (95% CI, -1.84 to -1.04; P &lt;.001); and -1.71 (95% CI, -2.09 to -1.33; P &lt;.001). The most commonly occurring adverse events with greater frequency in the lanadelumab treatment groups were injection site reactions (34.1% placebo, 52.4% lanadelumab) and dizziness (0% placebo, 6.0% lanadelumab). Conclusions and Relevance: Among patients with hereditary angioedema type I or II, treatment with subcutaneous lanadelumab for 26 weeks significantly reduced the attack rate compared with placebo. These findings support the use of lanadelumab as a prophylactic therapy for hereditary angioedema. Further research is needed to determine long-term safety and efficacy. Trial Registration: EudraCT Identifier: 2015-003943-20; ClinicalTrials.gov Identifier: NCT02586805

Multiwavelength studies of MHD waves in the solar chromosphere: An overview of recent results

The chromosphere is a thin layer of the solar atmosphere that bridges the relatively cool photosphere and the intensely heated transition region and corona. Compressible and incompressible waves propagating through the chromosphere can supply significant amounts of energy to the interface region and corona. In recent years an abundance of high-resolution observations from state-of-the-art facilities have provided new and exciting ways of disentangling the characteristics of oscillatory phenomena propagating through the dynamic chromosphere. Coupled with rapid advancements in magnetohydrodynamic wave theory, we are now in an ideal position to thoroughly investigate the role waves play in supplying energy to sustain chromospheric and coronal heating. Here, we review the recent progress made in characterising, categorising and interpreting oscillations manifesting in the solar chromosphere, with an impetus placed on their intrinsic energetics.Comment: 48 pages, 25 figures, accepted into Space Science Review

Search for direct production of charginos and neutralinos in events with three leptons and missing transverse momentum in √s = 7 TeV pp collisions with the ATLAS detector

A search for the direct production of charginos and neutralinos in final states with three electrons or muons and missing transverse momentum is presented. The analysis is based on 4.7 fb−1 of proton–proton collision data delivered by the Large Hadron Collider and recorded with the ATLAS detector. Observations are consistent with Standard Model expectations in three signal regions that are either depleted or enriched in Z-boson decays. Upper limits at 95% confidence level are set in R-parity conserving phenomenological minimal supersymmetric models and in simplified models, significantly extending previous results

Jet size dependence of single jet suppression in lead-lead collisions at sqrt(s(NN)) = 2.76 TeV with the ATLAS detector at the LHC

Measurements of inclusive jet suppression in heavy ion collisions at the LHC provide direct sensitivity to the physics of jet quenching. In a sample of lead-lead collisions at sqrt(s) = 2.76 TeV corresponding to an integrated luminosity of approximately 7 inverse microbarns, ATLAS has measured jets with a calorimeter over the pseudorapidity interval |eta| < 2.1 and over the transverse momentum range 38 < pT < 210 GeV. Jets were reconstructed using the anti-kt algorithm with values for the distance parameter that determines the nominal jet radius of R = 0.2, 0.3, 0.4 and 0.5. The centrality dependence of the jet yield is characterized by the jet "central-to-peripheral ratio," Rcp. Jet production is found to be suppressed by approximately a factor of two in the 10% most central collisions relative to peripheral collisions. Rcp varies smoothly with centrality as characterized by the number of participating nucleons. The observed suppression is only weakly dependent on jet radius and transverse momentum. These results provide the first direct measurement of inclusive jet suppression in heavy ion collisions and complement previous measurements of dijet transverse energy imbalance at the LHC.Comment: 15 pages plus author list (30 pages total), 8 figures, 2 tables, submitted to Physics Letters B. All figures including auxiliary figures are available at http://atlas.web.cern.ch/Atlas/GROUPS/PHYSICS/PAPERS/HION-2011-02